"Already, more than 24,000 physicians have registered with iQLearning and membership continues to increase," said Scott Clark, vice president, Innovex eHealth Solutions Group, a division of Innovex. "iQLearning uses the most current Web-based technologies to provide physicians a full range of medical services in a secure, online environment."

Market research indicates that approximately 90% of physicians in the U.S. have access to the Internet. This research also indicates that pharmaceutical companies may increase their investment in Internet-based marketing by 20 percent to more than a half a billion dollars by 2003.

iQLearning.com enables Innovex, a commercialization unit of Quintiles Transnational (Nasdaq: QTRN) to extend the reach and frequency of its sales forces. Quintiles' other U.S.-based commercial and consulting service groups will use the iQLearning portal to communicate and conduct business with customers in an online environment. These groups include Quintiles Late Phase, Quintiles Medical Communications, Quintiles Consulting and The Lewin Group.

Physicians registered with iQLearning can participate in live medical meetings, enroll in continuing medical education courses, request product samples, obtain product-specific medical information or "e-detailing," access e-mail and review comprehensive information on drug indications, dosages and interactions. Sales representatives can spend more time with physicians, directing them to pertinent areas on the iQLearning.com site.

"Pharmaceutical companies understand that Internet technologies provide an efficient and cost effective supplement to the traditional sales call," Clark said. "Through iQLearning.com, pharmaceutical companies can provide physicians with complete and up-to-date information about their products and services anytime and anywhere. iQLearning also has customer relationship management capabilities or a 'CRM backend' that allows us to target, cross sell, and integrate all commercial offerings directed at physicians in a cost effective manner for our pharmaceutical, biotech and health care customers."

About Innovex

Innovex, a unit of Quintiles, is a leading commercial solutions provider and offers sales and marketing services designed to accelerate the success of pharmaceutical, biotech and medical device products. Since 1996, Innovex has created more than 94 contract sales forces in the United States, with more than 12,500 representatives who have launched more than 100 established products and 37 new products. For more information, visit www.innovex.com.  

Quintiles Transnational Corp. is the world's leading provider of information, technology and services to bring new medicines to patients faster and improve healthcare. Headquartered near Research Triangle Park, North Carolina, Quintiles Transnational is a member of the S&P 500 and Fortune 1000. For more information visit the company's Web site at www.quintiles.com.  

Information in this press release contains "forward looking statements" regarding Quintiles and Innovex that involve risks and uncertainties that could cause actual results to differ materially, including without limitation, the risk that the market for our products and services will not grow as we expect, our ability to efficiently distribute backlog among therapeutic business units and match demand to resources, actual operating performance, the ability to maintain large client contracts or to enter into new contracts, changes in trends in the pharmaceutical industry, and the ability to operate successfully in new lines of business. Additional factors that could cause actual results to differ materially are discussed in Quintiles' recent filings with the Securities and Exchange Commission, including but not limited to its Annual Report on Form 10-K, its Form 8-Ks, and its other periodic reports, including Form 10-Qs.